-
Jefferies: Weakening Generic Drug Prices Putting Pressure On 3 Healthcare Stocks
Wednesday, May 17, 2017 - 2:12pm | 652Read More...Jefferies initiated coverage on Cardinal Health Inc (NYSE: CAH), AmerisourceBergen Corp. (NYSE: ABC) and McKesson Corporation (NYSE: MCK) Wednesday with Hold ratings. Jefferies’ analysis of prices paid by independent pharmacies for generic drugs leads analyst Brian Tanquilut to the conclusion...
-
McKesson Announces Acquisitions That Expands Its Oncology Expertise
Thursday, February 25, 2016 - 1:46pm | 254Read More...McKesson Corporation (NYSE: MCK) announced on Thursday two separate acquisitions to increase its specialty pharmaceutical distribution scale and oncology-focused pharmacy offerings, solutions for manufacturers and payers, and scope of community-based oncology and practice management services....
-
What's McKesson Worth?
Monday, May 11, 2015 - 11:34am | 931Read More...Pharmaceutical and medical supply distributor McKesson Corporation (NYSE: MCK) reports full year fiscal 2015 earnings on Tuesday, May 12 after market close. Models suggest that the stock is appropriately valued. At $229, MCK is not a long opportunity given current fundamentals and analyst...
-
JPMorgan Is Bullish On Rite Aid Before Earnings (Even After Disappointing March Sales)
Tuesday, April 7, 2015 - 12:12pm | 198Read More...In a report published Monday, JPMorgan analyst Lisa Gill upgraded shares of Rite Aid Corporation (NYSE: RAD) to Overweight from Not Rated with a $10 price target ahead of its fourth quarter results on Wednesday. Gill noted that Rite Aid's fourth quarter report will remain "somewhat...
-
Market Wrap For May 13: Markets Close Again At Record Highs
Tuesday, May 13, 2014 - 3:36pm | 2460Read More...U.S. stocks were mixed as a positive measurement of small business sentiment offset a disappointing retail data set. Following Monday's action, the S&P 500 and Dow indices not only traded at new historical-all time highs, but closed at record highs. In fact, the S&P 500 briefly traded...
-
Goldman Sachs: Rite Aid Shares Poised For Further Upside
Wednesday, March 12, 2014 - 3:53pm | 547Read More...Robert Jones, analyst at Goldman Sachs believes that the Drug Chain stores remain an attractive investment, but Rite-Aid (NYSE: RAD) is uniquely positioned to experience greater relative growth compared to the industry as a whole. Following Rite-Aid's announcement in February that it would be...
-
Market Wrap For March 12: Nasdaq Ends Losing Streak, Dow Mildly Lower
Wednesday, March 12, 2014 - 3:51pm | 2142Read More...U.S. stocks were little changed as investors found no new positive (or negative) developments from Ukraine and no new economic reports from China. Stanley Fischer, the nominee for Federal Reserve vice chairman will deliver a prepared testimony ahead of his confirmation at the Senate Banking...
-
Market Wrap For February 18: Dow Finishes Lower, Nasdaq Still Hot
Tuesday, February 18, 2014 - 4:47pm | 3229Read More...U.S. stocks traded mostly higher today despite a key measure of home builder confidence falling in February. The New York Fed's general business index also showed signs of vulnerability. Despite the weak economic data which is partially due to weather, the Nasdaq index rose for the eight...
-
Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases
Monday, January 13, 2014 - 4:52pm | 2370Read More...Investors and traders were in clear selling mode today ahead of a very busy week of earnings. The Dow suffered a triple digit point loss while the S&P 500 and Nasdaq suffered losses of more than one percent. There were no key economic data releases today. Related: Earnings Expectations For...
-
Earnings Expectations for the Week of May 6
Sunday, May 5, 2013 - 7:33pm | 1069Read More...Many of the S&P 500 have already reported their first-quarter results, but this week will bring plenty more earnings reports. Highlights will include earnings from Walt Disney and News Corp., Green Mountain Coffee Roasters and Whole Foods Market, Anadarko Petroleum and First Solar, as well as...
-
UPDATE: Auriga Lowers PT on McKesson from $96 to $95
Monday, August 1, 2011 - 7:50am | 166Read More...Auriga has published a report on McKesson (NYSE: MCK) reiterating the Buy rating and lowering the price target by one dollar. In the report, Auriga wrote, "We are reiterating our BUY rating on McKesson (MCK) following a strong start to FY12 in which results edged out expectations. Strength in...
-
Citi Reiterates Hold and PT of $89 on McKesson
Tuesday, June 28, 2011 - 7:51am | 40Read More...Citi reiterated its Hold rating on McKesson Corporation (NYSE: MCK). At the same time, Citi left its price target on the company's stock unchanged at $89. On Monday, McKesson closed the day at $81.98.
-
Deutsche Bank Updates 6/17
Friday, June 17, 2011 - 8:43am | 1447Read More...Deutsche Bank made a number of updates in a research report published today. Deutsche Bank initiated coverage of FXCM (NASDAQ: FXCM) with a Hold rating and a price target of $11. In a research report published today, Deutsche Bank states, "We are initiating coverage on FXCM, a leading provider of...
-
J.P. Morgan Maintains Overweight on McKesson
Monday, May 23, 2011 - 6:34am | 164Read More...J.P. Morgan is out with its report today on McKesson (NYSE: MCK), maintaining Overweight. In a note to clients, J.P. Morgan writes, "Our rating on McKesson is Overweight. We continue to point to the positive fundamental outlook for the drug distribution industry, and believe several key factors...
